Arch Therapeutics, Inc.

Arch Therapeutics, Inc.verified

ARTH

Price:

$0.0001

Market Cap:

$444.00

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.

Industry

Biotechnology

IPO Date

2013-01-02

Stock Exchange

OTC

Ticker

ARTH

The ROE as of November 2025 (TTM) for Arch Therapeutics, Inc. (ARTH) is 119.36%

According to Arch Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 119.36%. This represents a change of 300.33% compared to the average of 29.81% of the last 4 quarters.

Arch Therapeutics, Inc. (ARTH) Historical ROE (quarterly & annually)

How has ARTH ROE performed in the past?

The mean historical ROE of Arch Therapeutics, Inc. over the last ten years is 47.36%. The current 119.36% ROE has changed 152.05% with respect to the historical average. Over the past ten years (40 quarters), ARTH's ROE was at its highest in in the December 2019 quarter at 1.65%. The ROE was at its lowest in in the March 2016 quarter at -1066.30%.

Quarterly (TTM)
Annual

Average

47.36%

Median

97.49%

Minimum

-354.02%

Maximum

640.48%

Arch Therapeutics, Inc. (ARTH) ROE by Quarter and Year

Discovering the peaks and valleys of Arch Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 139.53%

Maximum Annual ROE = 640.48%

Minimum Annual Increase = -262.00%

Minimum Annual ROE = -354.02%

Quarterly (TTM)
Annual
YearROEChange
202393.01%-8.80%
2022101.98%-84.08%
2021640.48%139.53%
2020267.39%-20.74%
2019337.35%-195.29%
2018-354.02%1.20%
2017-349.82%84.53%
2016-189.57%-0.95%
2015-191.38%-262.00%
2014118.14%-111.92%

Arch Therapeutics, Inc. (ARTH) Average ROE

How has ARTH ROE performed in the past?

The current ROE of Arch Therapeutics, Inc. (ARTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

278.49%

5-year avg

288.04%

10-year avg

47.36%

Arch Therapeutics, Inc. (ARTH) ROE vs. Peers

How is ARTH’s ROE compared to its peers?

Arch Therapeutics, Inc.’s ROE is less than Orchid Ventures, Inc. (210.95%), greater than Discover Wellness Solutions Inc. (-34.50%), less than Molecular Templates, Inc. (148.79%), greater than Beleave Inc. (-341.61%), less than ACI Global Corporation (0%), less than MDEChem, Inc. (0%), greater than Micron Solutions, Inc. (-24.71%), greater than Allena Pharmaceuticals, Inc. (-160.99%), greater than IMV Inc. (-508.58%), greater than Mountain High Acquisitions Corp. (-683.12%),

Build a custom stock screener for Arch Therapeutics, Inc. (ARTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arch Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arch Therapeutics, Inc. (ARTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arch Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Arch Therapeutics, Inc.'s ROE?

How is the ROE calculated for Arch Therapeutics, Inc. (ARTH)?

What is the highest ROE for Arch Therapeutics, Inc. (ARTH)?

What is the 3-year average ROE for Arch Therapeutics, Inc. (ARTH)?

What is the 5-year average ROE for Arch Therapeutics, Inc. (ARTH)?

How does the current ROE for Arch Therapeutics, Inc. (ARTH) compare to its historical average?